CompuGroup Medical SE & Co. KGaA (LON:0MSD)
23.80
+0.12 (0.51%)
At close: Oct 17, 2025
LON:0MSD Revenue
CompuGroup Medical SE & Co. KGaA had revenue of 298.26M EUR in the quarter ending June 30, 2025, with 4.42% growth. This brings the company's revenue in the last twelve months to 1.20B, up 0.70% year-over-year. In the year 2024, CompuGroup Medical SE & Co. KGaA had annual revenue of 1.19B, down -3.39%.
Revenue (ttm)
1.20B EUR
Revenue Growth
+0.70%
P/S Ratio
1.07
Revenue / Employee
136.27K EUR
Employees
8,815
Market Cap
1.10B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.19B | -41.60M | -3.39% |
| Dec 31, 2023 | 1.23B | 53.10M | 4.52% |
| Dec 31, 2022 | 1.17B | 112.11M | 10.55% |
| Dec 31, 2021 | 1.06B | 193.49M | 22.26% |
| Dec 31, 2020 | 869.21M | 98.78M | 12.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 31.63B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |